Publication | Open Access
Serum glial fibrillary acidic protein in natalizumab-treated relapsing-remitting multiple sclerosis: An alternative to neurofilament light
13
Citations
28
References
2023
Year
sGFAP levels related to MRI markers of neuroinflammation and neurodegeneration.
| Year | Citations | |
|---|---|---|
Page 1
Page 1